
Key takeaways from AMCP’s recent AI Preconference in Houston, Texas, where leaders in pharmacy, healthcare, technology, and policy gathered for a half-day of deep, engaging discussions at AMCP 2025.
The White House made news last month with its blueprint to lower drug prices. But it's also important to note that biosimilars will play a crucial role in fostering competition and lowering costs. Biosimilars are the topic of my latest op-ed, "How to Foster Competition While Cutting Drug Costs," published last month in Morning Consult.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.